These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16876740)

  • 1. Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22 years.
    Ho IC; Milan DJ; Mansour MC; Mela T; Guy ML; Ruskin JN; Ellinor PT
    Heart Rhythm; 2006 Aug; 3(8):919-23. PubMed ID: 16876740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator endocarditis secondary to Candida albicans.
    Brown LA; Baddley JW; Sanchez JE; Bachmann LH
    Am J Med Sci; 2001 Sep; 322(3):160-2. PubMed ID: 11570782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus infection of implantable cardioverter-defibrillator.
    Cook RJ; Orszulak TA; Nkomo VT; Shuford JA; Edwards WD; Ryu JH
    Mayo Clin Proc; 2004 Apr; 79(4):549-52. PubMed ID: 15065620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
    Rivera NT; Bray N; Wang H; Zelnick K; Osman A; Vicuña R
    Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):193-201. PubMed ID: 24951637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual etiological agent of implantable cardioverter device endocarditis: Corynebacterium mucifaciens.
    Kaya A; Tekkesin AI; Kalenderoglu K; Alper AT
    Indian Heart J; 2016; 68(2):190-1. PubMed ID: 27133333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
    Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
    Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram.
    Grammes JA; Schulze CM; Al-Bataineh M; Yesenosky GA; Saari CS; Vrabel MJ; Horrow J; Chowdhury M; Fontaine JM; Kutalek SP
    J Am Coll Cardiol; 2010 Mar; 55(9):886-94. PubMed ID: 20185039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
    Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
    Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Jenkins SM; Baddour LM
    Mayo Clin Proc; 2008 Jan; 83(1):46-53. PubMed ID: 18174000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wound complications and treatment of the infected implantable cardioverter defibrillator generator.
    Gupta S; Prevel CD; Shaheen K; Wilkens E; Smith DJ; Kirsh MM; Bolling SF; Rees RS
    J Card Surg; 1993 Nov; 8(6):671-7. PubMed ID: 8286873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.
    Uslan DZ; Sohail MR; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM
    Clin Infect Dis; 2006 Sep; 43(6):731-6. PubMed ID: 16912947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans endocarditis with giant vegetation from an implantable cardioverter-defibrillator lead.
    Grunberg W; Al-Bataineh M; Weiss S
    Surg Infect (Larchmt); 2013 Feb; 14(1):157-9. PubMed ID: 23438207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
    Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The complications of implantable cardioverter-defibrillators and their treatment].
    Iorio D; Bonifazi R; Aquino TM; Santise G; Spampinato N
    G Chir; 1999 May; 20(5):238-40. PubMed ID: 10380366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right atrial giant vegetation protruding into right ventricle located on an implantable cardioverter-defibrillator lead.
    Guray Y; Demirkan B; Guray U; Celik G; Korkmaz S
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):542-5. PubMed ID: 19359993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.